Michael T. Osterholm: the future of ADVOCACY on AMR

  13 January 2021

In this first article, Dr Michael T. Osterholm, director of the Center for Infectious Disease Research and Policy (CIDRAP) at the University of Minnesota and, most recently, a member of President-elect Joe Biden’s Transition COVID-19 Advisory Board, describes how we can all become advocates for a new and better future, in spite of the increasingly complex threat of antimicrobial resistance.

 

Further reading: BSAC
Author(s): Michael Osterholm
Effective Surveillance  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

LifeArc

Antimicrobial Resistance Fighter Coalition

Bangalore Bioinnovation Centre

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS





Ambassador Network

Join the AMR Insights Ambassador Network today!

Connect to over 550 AMR professionals and students in 60 countries!

More information
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!
WordPress PopUp Plugin